根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$IsoRay, Inc.(ISR)$ CT ORDER - Confidential treatment order Filed: 2018-03-09 AccNo: 9999999997-18-002040 Size: 14 KB 网页链接
$IsoRay, Inc.(ISR)$ 内部交易: 2018-03-01,CEO and 董事会主席,LAVOY THOMAS C ,买入,50000普通股, $0.44
$IsoRay, Inc.(ISR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-02-09 AccNo: 0001437749-18-002157 Size: 3 MB 网页链接
$IsoRay, Inc.(ISR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-02-09 AccNo: 0001437749-18-002157 Size: 3 MB 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-02-08 AccNo: 0001437749-18-002063 Size: 211 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-01-24 AccNo: 0001437749-18-001082 Size: 42 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ CT ORDER - Confidential treatment order Filed: 2018-01-22 AccNo: 9999999997-18-000438 Size: 14 KB 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-01-08 AccNo: 0001437749-18-000404 Size: 471 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-01-04 AccNo: 0001437749-18-000265 Size: 17 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2017-12-19 AccNo: 0001437749-17-020901 Size: 31 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接